Ross Douglas T. - 15 Aug 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Scientific Officer
Signature
/s/ Douglas Ross
Issuer symbol
OCX
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 20:24:08 UTC
Previous filing
28 Mar 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +150,000 +738% $0.000000 170,317 15 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.